Biogened S.A. (WSE:BGD)
Poland · Delayed Price · Currency is PLN 24.30
+0.39 (1.64%)
At close: Sep 10, 2025
Biogened Income Statement
Financials in millions PLN. Fiscal year is January - December.
Millions PLN. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
| 112.75 | 110.93 | 95.56 | 79.62 | 65.32 | 48.33 | Upgrade | |
Revenue Growth (YoY) | 6.61% | 16.09% | 20.02% | 21.89% | 35.15% | 3.64% | Upgrade |
Cost of Revenue | 36.13 | 34.28 | 32.07 | 22.18 | 23 | 15.3 | Upgrade |
Gross Profit | 76.62 | 76.65 | 63.49 | 57.44 | 42.32 | 33.04 | Upgrade |
Selling, General & Admin | 68.42 | 66.88 | 54.62 | 41.86 | 35.29 | 30.02 | Upgrade |
Other Operating Expenses | -1.31 | 0.72 | 0.7 | 7.2 | 2.43 | 0.65 | Upgrade |
Operating Expenses | 67.11 | 67.6 | 55.32 | 49.06 | 37.73 | 30.68 | Upgrade |
Operating Income | 9.5 | 9.06 | 8.16 | 8.38 | 4.59 | 2.36 | Upgrade |
Interest Expense | -2.51 | -2.37 | -2.16 | -1.7 | -0.6 | -0.86 | Upgrade |
Interest & Investment Income | 0 | 0 | 0 | 0 | 0.01 | 0 | Upgrade |
Other Non Operating Income (Expenses) | -0.33 | -0.17 | 0 | -0.32 | -0.16 | 0.06 | Upgrade |
EBT Excluding Unusual Items | 6.67 | 6.52 | 6.01 | 6.36 | 3.84 | 1.55 | Upgrade |
Gain (Loss) on Sale of Investments | - | - | - | - | 0.49 | - | Upgrade |
Gain (Loss) on Sale of Assets | 0.19 | 0.32 | 0.88 | 0.03 | -0 | 0.62 | Upgrade |
Other Unusual Items | 0.85 | 0.85 | - | - | - | - | Upgrade |
Pretax Income | 7.71 | 7.69 | 6.89 | 6.39 | 4.33 | 2.18 | Upgrade |
Income Tax Expense | 1.88 | 1.87 | 1.79 | 3.01 | 2.37 | 0.93 | Upgrade |
Net Income | 5.83 | 5.82 | 5.1 | 3.38 | 1.96 | 1.24 | Upgrade |
Net Income to Common | 5.83 | 5.82 | 5.1 | 3.38 | 1.96 | 1.24 | Upgrade |
Net Income Growth | 8.84% | 14.22% | 50.74% | 72.46% | 57.92% | -2.37% | Upgrade |
Shares Outstanding (Basic) | 2 | 2 | 2 | 2 | 2 | 2 | Upgrade |
Shares Outstanding (Diluted) | 2 | 2 | 2 | 2 | 2 | 2 | Upgrade |
EPS (Basic) | 2.37 | 2.37 | 2.08 | 1.38 | 0.80 | 0.51 | Upgrade |
EPS (Diluted) | 2.37 | 2.37 | 2.08 | 1.38 | 0.80 | 0.51 | Upgrade |
EPS Growth | 8.84% | 14.22% | 50.74% | 72.46% | 57.92% | -2.37% | Upgrade |
Free Cash Flow | 0.86 | -1.49 | 7.72 | -3.35 | 1.57 | 6.88 | Upgrade |
Free Cash Flow Per Share | 0.35 | -0.61 | 3.14 | -1.36 | 0.64 | 2.80 | Upgrade |
Dividend Per Share | - | - | 0.500 | 0.400 | - | 0.200 | Upgrade |
Dividend Growth | - | - | 25.00% | - | - | - | Upgrade |
Gross Margin | 67.95% | 69.10% | 66.44% | 72.14% | 64.78% | 68.35% | Upgrade |
Operating Margin | 8.43% | 8.16% | 8.54% | 10.52% | 7.03% | 4.88% | Upgrade |
Profit Margin | 5.17% | 5.25% | 5.33% | 4.25% | 3.00% | 2.57% | Upgrade |
Free Cash Flow Margin | 0.77% | -1.35% | 8.08% | -4.21% | 2.41% | 14.23% | Upgrade |
EBITDA | 13.74 | 13.19 | 11.69 | 11.31 | 7.47 | 6.85 | Upgrade |
EBITDA Margin | 12.19% | 11.89% | 12.23% | 14.21% | 11.44% | 14.17% | Upgrade |
D&A For EBITDA | 4.24 | 4.13 | 3.52 | 2.94 | 2.88 | 4.49 | Upgrade |
EBIT | 9.5 | 9.06 | 8.16 | 8.38 | 4.59 | 2.36 | Upgrade |
EBIT Margin | 8.43% | 8.16% | 8.54% | 10.52% | 7.03% | 4.88% | Upgrade |
Effective Tax Rate | 24.35% | 24.33% | 26.01% | 47.09% | 54.71% | 42.95% | Upgrade |
Revenue as Reported | 112.75 | 110.93 | 95.56 | 79.62 | 65.32 | 48.33 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.